While constipation is a common side effect of GLP-1s, some patients with IBS, bloating, diarrhea, or irregular digestion notice that their symptoms actually improve while on the medication
The SELECT cardiovascular outcomes trial provided additional evidence of semaglutide's cardiovascular benefits
They definitely come with their own set of inconveniences (like stained clothes and a whole bunch of effort), but theyre significantly less harmful to your health than UV radiation or unpredictable, under-researched peptides
You Cant Lose Weight Most of our clients inquire about vitamin B12 shots because they heard it could help them lose weight
Amycretin, Novo Nordisks oral dual GLP-1/amylin agonist, showed 13% weight loss in early trials, signaling a move toward multi-pathway oral therapies
doi:10.1016/S2213-8587(24)00155-4 106